ArticleObstetrics and gynecology international2026
A Novel Uterus-Sparing Technique for Placenta Accreta Spectrum (PAS), at a Tertiary Center.
Article in Obstetrics and gynecology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Novel Uterus-Sparing Technique for Placenta Accreta Spectrum (PAS), at a Tertiary Center.Obstetrics and gynecology international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To present and evaluate the outcomes of a novel targeted devascularization technique for managing a placenta accreta spectrum (PAS). Design: Prospective observational study. Setting: The main tertiary care center in Saudi Arabia. Population: Sixty-seven referred pregnant women with a previous cesarean section scar, placenta previa, and sonographic diagnosis of PAS. Methods: Patients with PAS underwent targeted devascularization of the lateral sides of the uterus between cervix, and round ligament insertion at the time of caesarean delivery. Primary outcomes included uterine preservation rate and maternal morbidity. Secondary outcomes were transfusion requirements, surgical time, maternal and neonatal outcomes, estimated blood loss, transfusion rate, and bladder injury. Results: Among 67 patients, conservative surgery was successful in 95.5%, with a mean blood loss of 1.57 ± 0.81 L and 82.1% requiring blood transfusion. Bladder injury occurred in 22.4% and was managed intraoperatively. Surgical performance improved over time with reduced transfusion requirements ( Conclusions: Targeted devascularization of the lateral side of the uterus is a safe and effective uterus-sparing approach for PAS, associated with low morbidity and improved operative efficiency over time.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.